Work impact and cost-effectiveness of anti-CGRP monoclonal antibodies in patients with migraine

被引：0
|
作者：
Lazaro, C. [1 ]
Caronna, E. [1 ]
Alpuente, A. [1 ]
De la Torre, A. [2 ]
Torres, M. [1 ]
Pozo-Roisch, P. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Neurol Dept, Barcelona, Spain
[2] Univ Autonoma Barcelona, Headache Res Grp, Vall dHebron Inst Recerca, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-256
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [1] Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
    Iannone, Luigi Francesco
    De Cesaris, Francesco
    Ferrari, Anita
    Benemei, Silvia
    Fattori, Davide
    Chiarugi, Alberto
    CEPHALALGIA, 2022, 42 (13) : 1323 - 1330
  • [2] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Fred Cohen
    Hsiangkuo Yuan
    E. M. G. DePoy
    Stephen D. Silberstein
    Neurotherapeutics, 2022, 19 : 922 - 930
  • [3] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Cohen, Fred
    Yuan, Hsiangkuo
    DePoy, E. M. G.
    Silberstein, Stephen D.
    NEUROTHERAPEUTICS, 2022, 19 (03) : 922 - 930
  • [4] Anti-CGRP monoclonal antibodies in migraine: current perspectives
    Giamberardino, Maria Adele
    Affaitati, Giannapia
    Curto, Martina
    Negro, Andrea
    Costantini, Raffaele
    Martelletti, Paolo
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (08) : 1045 - 1057
  • [5] Anti-CGRP monoclonal antibodies: breakthrough in migraine therapeutics
    Krishnaswamy, Ratna
    Malik, Bilal Haider
    Khan, Safeera
    Gupta, Deepti
    Islam, Muhammad
    Mandel, Shrawan Kumar
    Rutkofsky, Ian H.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2019, 23 (03) : 26 - 33
  • [6] Anti-CGRP monoclonal antibodies in migraine: current perspectives
    Maria Adele Giamberardino
    Giannapia Affaitati
    Martina Curto
    Andrea Negro
    Raffaele Costantini
    Paolo Martelletti
    Internal and Emergency Medicine, 2016, 11 : 1045 - 1057
  • [7] Late Response to Anti-CGRP Monoclonal Antibodies in Migraine
    Barbanti, Piero
    Aurilia, Cinzia
    Egeo, Gabriella
    Torelli, Paola
    Proietti, Stefania
    Cevoli, Sabina
    Bonassi, Stefano
    NEUROLOGY, 2023, 101 (11) : 482 - 488
  • [8] Anti-CGRP monoclonal antibodies: migraine prevention in patients with psychiatric comorbidities
    di Cola, Francesca Schiano
    Ceccardi, Giulia
    Caratozzolo, Salvatore
    Bolchini, Marco
    Di Pasquale, Michele
    Rao, Renata
    Padovani, Alessandro
    CEPHALALGIA, 2023, 43 (1supp) : 252 - 253
  • [9] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [10] Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients
    Castrillo, Ana
    Mendoza, Amelia
    Caballero, Lorena
    Cerdan, Debora
    Rodriguez, Maria Fernanda
    Guerrero, Pilar
    Tabernero, Cesar
    Ferrero, Marta
    Benito, Ines
    Marin, Laura
    Duarte, Jacinto
    MEDICINA CLINICA, 2023, 160 (08): : 341 - 346
12345